15-yr-old student shoots school director for complaining against him to parents

Bengaluru, Jul 22: A total of 4,764 new COVID-19 cases and 55 deaths were reported in Karnataka in the last 24 hours.

Out of the new cases, 2,050 cases were reported in Bengaluru on Wednesday.

The total number of active cases stands at 47,069, said the state Health Department.

Death toll rises to 1,519 in the state.

Kochi, Jul 15: Alisha P Shaji, a commerce student from Kerala's Kochi scored 499 out of 500 in the Central Board of Secondary Education (CBSE) class 12 results declared on Monday, wants to pursue a career in economics.

While talking to news agency on Tuesday, she said that she never joined coaching classes.

"I was surprised after knowing the unexpected result. I never expected this, I expected close to 98 per cent. I had five subjects to write but I could attempt only three as two were postponed. I am sad that I could not attempt them, but I am happy that I scored 100 in those subjects. In future, I want to pursue a degree in economics," she said.

"My friends, family and teachers are very supportive and I am thankful to them. I never went to tuitions. I used to study four to five hours a day," she added.

Alisha further said that she wants to give the message that it is okay to start late, but continuity is key to achieve good results.
CBSE on Monday had declared the results for Class 12 examinations 2020.

As per CBSE, with 88.78 per cent pass percentage this year for Class 12, the pass percentage has increased by 5.38 per cent. Last year, the pass percentage was 83.40 per cent. 

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.